中华临床营养杂志
中華臨床營養雜誌
중화림상영양잡지
CHINESE JOURNAL OF CLINICAL NUTRITION
2009年
4期
220-223,插2
,共5页
王凝%展玉涛%史小林%高福生%谢新纪%刘宾
王凝%展玉濤%史小林%高福生%謝新紀%劉賓
왕응%전옥도%사소림%고복생%사신기%류빈
肝硬化%门脉高压性胃病%诱导型一氧化氮合酶%氨基胍
肝硬化%門脈高壓性胃病%誘導型一氧化氮閤酶%氨基胍
간경화%문맥고압성위병%유도형일양화담합매%안기고
Cirrhosis%Portal hypertensive gastropathy%Inducible nitric oxide synthase%Aminogutmidine
现胃黏膜iNOS高表达,且逐步加重,iNOS在门脉高压性胃病形成中可能起重要作用;AG可明显减轻门脉高压性胃黏膜病变程度,其机制可能主要通过抑制胃黏膜iNOS表达.
現胃黏膜iNOS高錶達,且逐步加重,iNOS在門脈高壓性胃病形成中可能起重要作用;AG可明顯減輕門脈高壓性胃黏膜病變程度,其機製可能主要通過抑製胃黏膜iNOS錶達.
현위점막iNOS고표체,차축보가중,iNOS재문맥고압성위병형성중가능기중요작용;AG가명현감경문맥고압성위점막병변정도,기궤제가능주요통과억제위점막iNOS표체.
arkably increases with the development of cirrhosis,which may play an important role in the development of PHG.AG may remarkably ameliorate the degree of PHG，mainly by inhibiting the expression of iNOS in gastric musosa.
